Mutations in optineurin (OPTN) are associated with several human disorders including amyotrophic lateral sclerosis (ALS) and primary open-angle glaucoma (POAG). OPTN is known to be a multifunctional autophagy receptor that plays important roles in NF-jB signaling, vesicle trafficking, maintenance of the Golgi apparatus and autophagy. Given that a loss of neurons and an abnormal aggregation of disease proteins are two key features of neurodegenerative diseases, protein quality control systems are considered to be tightly associated with neurodegeneration. In this study, we investigated the involvement of the ubiquitin-proteasome system (UPS) and the autophagy-lysosome pathway, two major intracellular protein quality control systems, in the regulation of wild-type (WT) OPTN, ALS-linked mutant E478G OPTN and POAG-linked mutant E50K OPTN. Our data revealed that the UPS, not the autophagy-lysosome pathway, is the major system for degradation and aggregation of OPTN. Moreover, we found that Hrd1, an E3 ubiquitin ligase, could play an important role in the protein quality control of OPTN. Our results demonstrated that overexpression of Hrd1 increased the proteasomal degradation and microtubuledependent aggresome formation of OPTN in the microtubular organizing center, whereas knockdown of Hrd1 stabilized OPTN and inhibited aggresome formation of OPTN.
Introduction
Optineurin (OPTN), a protein encoded by the OPTN gene, is also known as FIP-2 (1). OPTN has 16 exons, and the OPTN protein consists of 577 amino acids (2) . The structure of OPTN includes multiple coiled coil domains, an LC3-interacting region (LIR), a RING finger domain and a ubiquitin-binding domain (UBAN) (3, 4) . A number of proteins have been identified to bind OPTN.
For example, HACE1, receptor-interacting protein (RIP), myosin VI and huntingtin (htt) bind to the C-terminal of OPTN, while TANK-binding kinase 1 (TBK1) and Rab8 bind to the N-terminal of OPTN (4) (5) (6) . OPTN has a sequence in UBAN similar to that of nuclear factor kappa B (NF-jB) essential modulator (NEMO) (7) , and OPTN can bind to ubiquitinated RIP and negatively regulate tumor necrosis factor-a (TNF-a)-induced NF-jB activation (7) .
In addition, OPTN plays an important role in membrane trafficking, formation of the Golgi ribbon, and maintenance of the Golgi complex (8, 9) . It has been reported that OPTN negatively regulates Rab8 function through TBC1 domain family member 17 (TBC1D17) (10) . OPTN binds to poly-ubiquitinated cargoes via its UBAN and brings the cargoes to autophagosomes via its LIR, which interacts with LC3 on the phagophore (11, 12) . Phosphorylated OPTN may promote the selective autophagy of ubiquitin-covered cytosolic Salmonella (xenophagy) (13) . Recent studies showed that OPTN is a selective autophagy receptor for mitophagy (14) (15) (16) .
Recent studies have shown that OPTN dysfunction is associated with a number of diseases, including primary open-angle glaucoma (POAG), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Paget's disease of bone (6) . POAG is a major type of glaucoma in adults. The progressive degeneration of retinal ganglion cells and their axons may cause visual field loss or permanent bilateral blindness in POAG patients. OPTN mutation was first identified in families with autosomal dominant adult-onset POAG (17) . The most common OPTN mutation identified in POAG is the E50K mutation, accounting for 10-15% of autosomal dominant POAG families. In transgenic mice overexpressing the OPTN E50K mutant, thinning of all retinal cell layers and degeneration of retinal ganglion cells were observed (18) . Thereafter, OPTN mutations were identified in association with ALS and other human disorders (19) (20) (21) (22) . ALS is a neurodegenerative disease characterized by the progressive degeneration of motor neurons. The clinical manifestations of ALS include dysphagia, pyramidal signs, progressive atrophy and muscle weakness. Mutations of OPTN were found to have an incidence rate of $1-4% in familial ALS (fALS) patients (23, 24) . It has been shown that ALS-linked E478G is a heterozygous missense mutation that occurs in the UBAN domain of OPTN (19) .
Abnormal accumulation of disease-associated proteins is one of the major features in neurodegenerative diseases (25) . For example, extracellular protein aggregates were observed in Alzheimer's disease (AD); cytoplasmic aggregates were observed in Parkinson's disease (PD) and ALS; both cytoplasmic and intranuclear protein aggregates were observed in polyglutamine (polyQ) diseases (26) . Although the role of protein aggregation in the pathogenesis of these diseases is still not fully understood, one common feature of protein aggregates in various neurodegenerative diseases is ubiquitin reactivity, indicating that the aggregation of proteins in diseases may be regulated by ubiquitin signaling and ubiquitin-associated proteins. Accordingly, OPTN is an ubiquitin-binding protein, and OPTN-positive aggregates have been identified in brains in many neurodegenerative diseases, including AD, PD, Huntington's disease (HD) and ALS/FTD (6, 27) .
In eukaryotic cells, there are two major protein quality control systems: the ubiquitin-proteasome system (UPS) and the autophagy--lysosome pathway (28) . The UPS is highly selective for the degradation of short-lived proteins, and the autophagylysosome pathway is critical for the turnover of long-lived cytosolic proteins and cellular organelles (29) . Degradation of misfolded proteins via the UPS involves two consecutive processes: first the substrate protein is tagged via covalent attachment of ubiquitin molecules, and then the ubiquitin-tagged protein is degraded by the 26S proteasome. During the first stage, ubiquitin is linked to the protein substrate through a cascade utilizing E1 (ubiquitin-activating), E2 (ubiquitin-conjugating) and E3 (ubiquitin-ligating) enzymes (30) . E3 ligases play a particularly important role in conferring specificity to the ubiquitination process, possibly through selectively recognizing distinctive sets of substrates and transferring ubiquitin(s) to the substrates (31) . If the quality control system fails to clear the aggregated proteins, the aggregates may be sequestered to the microtubule organizing center (MTOC) and form a large inclusionbody-like structure called an aggresome (32, 33) . Aggresome formation is thought to be a protective process by which the cells handle stress or toxic actions (33, 34) .
Endoplasmic reticulum-associated degradation (ERAD) is a protein quality control system for the degradation of misfolded proteins in the ER (35) . Many unassembled or misfolded proteins are transported to the ER membrane and degraded by ERAD (36) (37) (38) . Hrd1, also named synoviolin, is a protein encoded by SYVN1 (synovial apoptosis inhibitor 1). Hrd1 acts as a mammalian ERAD E3 ligase that can accept ubiquitin from E2 ubiquitin-conjugating enzyme 7 (UBC7) and transfer it to substrates to guiding their eventual degradation (39). The expression level of Hrd1 is increased following ER stress to protect the cell against ER stress-induced cytotoxicity (40) (41) (42) . Hrd1 has been shown to promote ubiquitination and degradation of many proteins associated with neurodegenerative diseases, including prion protein (PrP) in prion disease, amyloid precursor protein (APP) in AD, a-synuclein in PD, mutant huntingtin (N-terminus of huntingtin) containing expanded polyglutamine (polyQ) in HD and neuroserpin (43) (44) (45) (46) (47) .
Although the cellular functions of OPTN have been widely studied (47) , the cellular turnovers of OPTN and its mutants are still not fully understood. In this study, we show that the OPTN E50K mutant is relative unstable and is mainly degraded by the proteasome, whereas the OPTN E478G mutant is very stable in cells. Moreover, Hrd1 induces the proteasomal degradation of wild-type and E50K OPTN. Interestingly, Hrd1 promotes the sequestrations of wild-type and E478G OPTN to aggresomes in a microtubular transport system-dependent manner when the UPS is blocked. Thus, the current study reveals a critical role of Hrd1 in the degradation and aggresome formation of OPTN.
Results
Wild-type and mutant OPTN are differentially degraded by the UPS First, we investigated the cellular distribution of wild-type (WT) and mutant OPTN. In HEK 293 cells overexpressing green fluorescent protein (GFP)-tagged or HA-tagged OPTN proteins, WT and E50K OPTN formed vesicular structures (punctate cellular compartments with diameter <3 lm) in most cells, while E478G OPTN was diffusely expressed in the cytoplasm (Fig. 1A) . These observations were consistent with recent studies (4, 8, 10, 14, 15, 48) . We next examined the degradation rates of these three forms of OPTN. In cells that were treated with cycloheximide (CHX) to block protein synthesis, E50K OPTN was degraded more quickly than WT OPTN. However, E478G OPTN is more stable than WT OPTN (Fig. 1B and C) . To further investigate the cellular turnover of OPTN, we overexpressed WT, E50K or E478G OPTN in HEK 293 cells and treated the cells with either a proteasome or lysosome inhibitor. As shown in Fig. 1D and E, the levels of WT and E50K OPTN were increased in the presence of the proteasome inhibitor MG132 but not the lysosome inhibitor Bafilomycin A1 (an autophagy-lysosome inhibitor that blocks the fusion between autophagosomes and lysosomes). However, the E478G OPTN level was not changed by either of the inhibitors. CHX chase analysis also showed that MG132 treatment increased the stability of WT and E50K OPTN but not E478G OPTN (Fig. 1F-I ). These data indicate that inhibition of the GFP-tagged WT, E50K or E47G OPTN. Twenty-four hours after transfection, the cells were treated with 100 lg/ml CHX. The cell lysates were collected at different time and processed for immunoblot analysis with monoclonal GFP or GAPDH antibody. (C) The relative densities of GFP-tagged OPTNs were quantified from three independent experiment as described in B. Data were presented as mean 6 SEM. **P < 0.01, one-way ANOVA. (D) HEK 293 cells were transfected as described in B. Twenty-four hours later, the cells were treated with 10 lM MG132 or 100 nM Bafilomycin A1 (Bafi) for 12 h. The cell lysates were collected and subjected to immunoblot analysis using antibody against GFP or GAPDH. (E) The quantitative data from three independent experiments as D were shown. Data were presented as mean 6 SEM. **P < 0.01, oneway ANOVA. (F) HEK 293 cells were transfected as described in B. Twenty-four hours after transfection, the cells were incubated with MG132 or Bafilomycin A1 (Bafi) in the present of CHX for the indicated time. The cell lysates were used for immunoblot analysis with mouse monoclonal anti-GFP (left side) and GAPDH antibodies (right side). (G-I) Quantification of the data presented in F were shown. Data were indicated mean6 SEM. **P < 0.01, one-way ANOVA.
proteasome leads to an abnormal accumulation of WT and E50K OPTN proteins but not E478G OPTN, suggesting that different forms of OPTN are differentially regulated by the proteasome.
WT and E478G OPTN, but not E50K OPTN, are prone to forming aggresome-like structures
We already observed the different cellular localizations of the three forms of OPTN. To further characterize the effect of the proteasome on the regulation of OPTN, we transfected cells with WT or mutant OPTN and treated the cells with MG132. In cells treated with MG132, WT OPTN formed large aggresomelike structures ( Fig. 2A and B) . Notably, E50K OPTN tended not to form "compact" aggresome-like structures but formed preaggresome-like structures after MG132 treatment ( Fig. 2C and  D) . Like WT OPTN, E478G OPTN formed aggresome-like structures, but of relatively small sizes ( Fig. 2E and F) . These data suggest that OPTN aggregation is associated with UPS. We then examined the co-localization of OPTN with LC3 and LAMP1, the autophagy and lysosome markers. After treatment with Bafilomycin A1 that blocks the fusion between autophagosomes and lysosomes, WT and E50K OPTN co-localized with LC3-positive autophagosomes but not with LAMP1-positive lysosomes ( Fig. 2A-D) . However, E478G OPTN did not co-localize with autophagosomes or lysosomes ( Fig. 2E and F) . These data suggest that an inhibition of the autophagy-lysosome pathway will lead to OPTN accumulation in autophagosomes, but not into aggregates or aggresome-like structures. Taken together, our results indicate that the proteasome, but not the autophagy-lysosome pathway, regulates degradation and aggregation of OPTN.
Hrd1 promotes ubiquitination and degradation of OPTN
Since WT OPTN and E50K OPTN are degraded by the UPS, we next examined whether E3 ligases could be involved in the degradation of OPTN. We co-transfected the cells with WT OPTN and several mammalian E3s including Hrd1, trim5, RNF6, trim8 and trim26. The level of WT OPTN was markedly decreased in the presence of Hrd1 but not in the presences of other E3s (Fig. 3A, B and data not shown). As Hrd1 is a well-known E3 ubiquitin ligase, we wondered whether it would affect OPTN ubiquitination. Using immunoprecipitation assays, we observed strikingly increased ubiquitination of OPTN in the presence of Hrd1 (Fig. 3C and Supplementary Material, Fig. S1 ), and an association between Hrd1 and OPTN (Fig. 3C ). In addition, Hrd1 could promote both K48R and K63R poly-ubiquitination of OPTN (Supplementary Material, Fig. S2 ). We found that Hrd1 overexpression increased the degradation of both WT and E50K OPTN but not E478G OPTN ( Fig. 3D and E) , indicating that Hrd1 could selectively target WT and E50K OPTN for proteasomal degradation. Depletion of endogenous Hrd1 by siRNA targeting Hrd1 increased the protein levels of WT and E50K OPTN, effects of which were similar to MG132 treatment ( Fig. 3F-I ).
Deletion of RING finger domain in Hrd1 impairs OPTN ubiquitination and aggresome-like structure formation
Previously, studies have showed that the RING finger domain of Hrd1 is the most essential domain related to E3 ligase activity of Hrd1 (49), so we next tested the effects of a RING finger deletion mutant of Hrd1 (Hrd1 DRING) on OPTN ubiquitination and aggregation. In comparison to WT Hrd1, Hrd1 DRING finger failed to increase ubiquitination of WT, E50K and E478G OPTN in co-immunoprecipitation assays ( Fig. 4A and Supplementary  Material, Fig. S3 ). Furthermore, RING finger deletion abolished the ability of Hrd1 to induce aggresome and pre-aggresome-like structure formation of WT, E50K and E478G OPTN, and it also abolished the co-localization of Hrd1 and OPTN (Fig. 4B-E) .
Hrd1 regulates OPTN aggresome formation in a dynein motor-and microtubule-dependent manner Aggresomes usually localize in the MTOC (at the microtubule minus end) of the cell and co-localize with aggresome markers such as c-tubulin (32, 34, 50) . In our observations, WT and E478G OPTN inclusions that look like aggresome co-localized with c-tubulin in cells expressing Hrd1 (Fig. 5A ), indicating that they are indeed aggresomes. In contrast, E50K OPTN formed punctate inclusions around c-tubulin; therefore, we named those structures as pre-aggresome-like structures. Since aggresome formation is microtubule dependent (32, 33) and it has been reported that HDAC6 regulates aggresome formation by working as an adaptor for anchoring substrate proteins to the dynein motor for delivery to the MTOC (51), we tested the effects of nocodazole (a microtubular depolymerizing agent), TSA (an inhibitor of histone deacetylase) or EHNA (an inhibitor of dynein) on OPTN aggresome formation. In cells treated with MG132, aggresomes of OPTN were surrounded by microtubule (a-tubulin) (Fig. 5B, left panel) , indicating that those aggresomes were enriched in the MTOC. Our results showed that nocodazole treatment could broke the intact microtubule network as shown by a-tubulin staining (Fig. 5B, the second panel on left) . Moreover, nocodazole, TSA and EHNA all prevented MG132-induced OPTN aggresome formation and resulted in the wide dispersion of small aggregates ( Fig. 5B and C) , indicating that aggresome formation by OPTN depended on an intact microtubule network and HDAC6/dynein motor complex.
We next tested the effect of endogenous Hrd1 on OPTN aggresome formation. In control cells (cells transfected with sicontrol) treated with MG132, WT OPTN formed aggresomes that co-localized with c-tubulin. However, in Hrd1-depleted cells treated with MG132, WT OPTN failed to form mature aggresomes and instead formed small aggregates, suggesting that endogenous Hrd1 is required for aggresome formation by OPTN ( Fig. 6A and B) . Moreover, we found that knockdown of OPTN did not affect MG132-induced Hrd1 aggregation (Supplementary Material, Fig. S4 ), indicating that OPTN itself is an aggresomeprone protein under proteasomal inhibition and does not affect Hrd1-mediated protein aggregation. Taken together, our results identify the E3 ubiquitin ligase Hrd1 as a crucial regulator of OPTN aggresome formation.
Discussion
In healthy cells, protein homeostasis is maintained by balancing the cellular protein control systems that are responsible for protein synthesis, folding, aggregation and degradation (52) . Misfolded proteins can occur because of incorrect protein synthesis, mutations, high levels of protein expression, or cellular stress (53) . It is estimated that the proportion of misfolded proteins among newly synthesized proteins could be over 30% (54) . Therefore, cellular protein quality control systems are very important for cellular homeostasis. The UPS and molecular chaperone system initiate the first defense against accumulation of FLAG-RNF6, FLAG-trim8 or FLAG-trim26. Twenty-four hours after transfection, the cell lysates were collected for immunoblot analysis with mouse monoclonal antibody against GFP or GAPDH. (B) The quantitative data from three independent experiments as in A were shown. Data were presented as mean 6 SEM. **P < 0.01, one-way ANOVA. (C) HEK 293 cells were co-transfected with GFP or GFP-WT OPTN with FLAG tag or FLAG-Hrd1. Twenty-four hours after incubation with 10 lM MG132, the supernatants of the cell lysates were immunprecipitated with rabbit polyclonal antibodies against GFP. (D) HEK 293 cells were co-transfected with GFP-WT, E50K or E478G OPTN along with FLAG tag or FLAG-Hrd1. The cell lysates were subjected to immunoblot analysis with GFP or GAPDH antibody. (E) The quantitative data from three independent experiments as in D were shown. Data were presented as mean 6 SEM. **P < 0.01, one-way ANOVA. (F) Endogenous Hrd1 was knocked down with siRNA in HEK 293 cells. Forty-eight hours later, cells were transfected with GFP-WT OPTN. Another 24 h later, the cells were incubated with or without 10 lM MG132 for 12 h. Finally, the cell lysates were collected for immunoblot analysis using antibody against GFP or GAPDH. (G) The quantitative data from three independent experiments as in F were shown. Data were presented as mean 6 SEM. **P < 0.01, one-way ANOVA. (H) Cells were processed as F except for overexpressing GFP-E50K instead of GFP-WT-OPTN. (I) The quantitative data from three independent experiments as in H were shown. Data were presented as mean 6 SEM. **P < 0.01, one-way ANOVA.
misfolded proteins (55) (56) (57) . In eukaryotic cells, most proteins are first tagged by ubiquitin and then digested into amino acids or small peptides by the 26S proteasome. The UPS is the primary "quality control" mechanism in the degradation of misfolded proteins (53, 58) . In the UPS, E3s play an important role in regulating misfolded protein degradation by the proteasome. Hrd1 acts as an ERAD E3 ligase that specifically accepts ubiquitin from the ER-associated E2 UBC7 and transports ubiquitin molecules to substrates, thus promoting the retrotranslocation and proteasomal degradation of substrates in the cytosol (59). Hrd1 or FLAG-Hrd1 DRING finger. Twenty-four hours after transfection, the cell were treated with 10 lM MG132 for additional 12 h. Then the cell lysates were collected and subjected to immunoprecipitation (IP) and immunoblot (IB) using antibodies against ubiquitin (Ub) or GFP. (B) HEK 293 cells were co-transfected with GFP-WT OPTN and FLAG, FLAG-Hrd1 or FLAG-Hrd1 DRING finger. Twenty-four hours after transfection, the cells were fixed and subjected to immunofluorescent staining with FLAG antibody. DAPI (blue) was used for nuclear staining. Scale bars, 10 lm (C, D) Experiments were performed as in B, except that cells were transfected with GFP-E50K-OPTN or GFP-E478G-OPTN, instead of GFP-WT-OPTN. Scale bars, 10 lm. (E) The quantification of Hrd1/OPTN co-aggregation (co-localization) in B-D. Data from three independent experiments were presented as means 6 S.E.M., **P < 0.01, one-way ANOVA.
It has been shown that Hrd1 is beneficial in several neurodegenerative diseases (44, 45, 60, 61) . In this study, we show that Hrd1 can interact with and ubiquitinate OPTN (Fig. 4 and Supplementary Material, Figs. S1-S3) to promote OPTN degradation (Figs. 3 and 4) . Thus, Hrd1 may function as a quality control E3 to facilitate OPTN degradation.
Interestingly, although Hrd1 is an ER membrane-spanning E3, it has been shown to regulate several substrates in the cytosol and nucleus, such as mutant p53, a-synuclein and mutant huntingtin containing expanded polyglutamine tracts (44, 45, 62) . A possible mechanism for Hrd1-mediated degradation of these non-ER-resident proteins is that the RING finger activity domain localizes outside of the ER membrane, and this ligase activity allows it to catalyze the ubiquitination of cytosolic substrates. We hypothesize that the cytosolic side of Hrd1 associates with OPTN and recruits cytoplasmic OPTN close to the ER membrane, and promotes the poly-ubiquitination of OPTN there. Eventually, a protein complex enriched with ubiquitinated OPTN, Hrd1 and possibly other ubiquitinationassociated factors may form close to the ER surface. In our study, we show that the RING finger domain in Hrd1 is necessary for OPTN ubiquitination (Fig. 4B) , suggesting that Hrd1 E3 ligase activity is critical for the regulation of OPTN degradation by the proteasome. Moreover, in our observations, other E3s, such as trim5, RNF6, trim8 and trim26, had no effect on OPTN degradation (Fig. 3A and B) , further suggesting that Hrd1 is a specific E3 ligase for OPTN. Notably, E478G OPTN (with mutation in UBAN that directly abolishes the binding to ubiquitin) was resistant to proteasomal degradation (Figs. 1F and 3D) , despite that Hrd1 could increase the ubiquitination of E478G OPTN (Supplementary Material, Fig. S2 ). We suppose that other ubiquitin-associated factors, which can interact with the UBAN domain of OPTN, may cooperate with Hrd1 and facilitate the proteasomal degradation of WT and E50K OPTN, but not E478G OPTN.
Neurodegenerative disease-associated proteins are easily misfolded and escape the degradation systems to form protein oligomers or aggregates. In detail, when the UPS and molecular Figure 5 . Hrd1 regulates OPTN aggresome formation in a dynein motor/microtubule-dependent manner. (A) HEK 293 cells were co-transfected with GFP-WT, E50K or E478G OPTN, along with FLAG-Hrd1 for 24 h. Antibody against c-tubulin was used for immunofluorescence staining. DAPI (blue) was used for nuclear staining. Notably, OPTN inclusion with a compact structure and 3-10 lm in diameter is defined as "aggresome (big aggresome)"; that with a compact structure and 2-3 lm in diameter is defined as "small aggresome"; OPTN inclusions with punctate structures around c-tubulin are defined as "pre-aggresome-like structures". Scale bars, 10 lm. chaperone system fail to dispose of the misfolded proteins, particularly in stress-induced situations, misfolded proteins may accumulate to form toxic oligomers (34) . These oligomers can be recognized by the protein quality control system as toxic intermediate species and will be further deposited into aggregates or aggresomes (50) . The process of aggresome formation is in fact a stress response that neutralizes the toxicity from protein oligomers or aggregates by compacting them into a tight structure (34, 63) . Aggresomes were shown to be associated with many neurodegenerative diseases including AD, PD, ALS, HD and others (63) . In this study, we show that Hrd1 not only regulates the proteasomal degradation of OPTN but also regulates the aggresomal sequestration of OPTN (Figs. 5 and 6 ). Similar to CHIP-and ataxin-3-mediated aggresome formation of targeted proteins (64, 65) , the ubiquitin signal in association with the RING finger domain in Hrd1 is necessary for OPTN aggresomal formation (Fig. 4) , suggesting that Hrd1 E3 ligase activity and the ubiquitin signal are critical for the aggresomal formation of OPTN. Taken together, our research shows a model in which Hrd1 is a regulator in protein quality control of OPTN (Fig. 7) . Hrd1 interacts with OPTN and regulates its ubiquitination to regulate OPTN proteasomal degradation and aggresomal sequestration. Although previous studies showed that Hrd1 played a role in promoting proteasomal degradation of substrate proteins, this study extends our knowledge by revealing that Hrd1 also functions in protein aggresome formation.
Materials and Methods

Plasmid constructs
GFP-tagged WT OPTN and mutant E50K plasmids were obtained from Dr. Ghanshyam Swarup (Centre for Cellular and Molecular Biology, India). myc-trim5, FLAG-RNF6, FLAG-trim8 and FLAG-TRIM26 plasmids were provided by Dr. Xinliang Mao (Soochow University, China). LC3 (LC3B)-RFP, LAMP1-RFP and FLAG-Hrd1 plasmids were described previously (65) (66) (67) . An E478G point mutation of OPTN and deletion mutants of Hrd1 were generated using a MutanBEST kit (Takara). Mutant E478G OPTN was cloned by site-directed mutagenesis PCR using the following primers: sense 
Cell culture, transfection and chemicals
Human embryonic kidney 293 (HEK 293) cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Life Technologies) supplemented with 10% fetal bovine serum (FBS, Gibco) with penicillin (100 mg/ml) and streptomycin (100 mg/ml) and maintained in a humidified atmosphere containing 5% CO 2 at 37 C.
The cells were transfected with either plasmids or siRNA using Lipofectamine 2000 (Invitrogen) or Lipofectamine RNAiMAX reagent (Invitrogen) in Opti-MEM (OMEM; Gibco) with or without serum. CHX, nocodazole, erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) and trichostatin (TSA) were purchased from Sigma. MG132 was purchased from Calbiochem, and Bafilomycin A1 (Bafi) was purchased from Selleck.
Immunoblot analysis and antibodies
Cells were collected and lysed in 1Â SDS lysis buffer containing 50 mM Tris-HCl (pH7.6), 150 mM NaCl, 0.5% sodium deoxycholate, 1% Nonidet P-40 and protease inhibitor cocktail (Roche). The cell lysates were then separated by SDS-PAGE and transferred onto a polyvinylidene difluoride membrane (Millipore). The membranes were blocked with 5% nonfat milk for 1 h at room temperature. The following primary antibodies were used: mouse monoclonal antibodies against GFP (Santa Cruz Biotechnology), GAPDH (Proteintech), CDC25A (Proteintech) and rabbit polyclonal antibodies against LC3 (Novus Biologicals). The secondary antibodies used were horseradish peroxidaseconjugated sheep anti-mouse or anti-rabbit (Amersham Bioscienses). The proteins were detected using the ECL detection kit (Merck Millipore).
Immunofluorescence
For immunofluorescence assay, HEK 293 cells were washed with phosphate-buffered saline (PBS) (pH 7.4) three times and fixed with 4% paraformaldehyde or ice-cold methanol at room temperature for 5 min. The cells were permeabilized with 0.1% Aggresome formation of OPTN relies on the dynein motor complex and microtubular transport system, which can be accelerated by proteasomal inhibition. In comparison to WT OPTN, E50K OPTN is easier to go through proteasomal degradation, but E50K OPTN is harder to be sequestered into mature aggresome. Meanwhile, E478G
OPTN is resistant to be degraded by the proteasome, and can be sequestered into aggresome but a less extent than WT OPTN.
Triton X-100 for 5 min and then washed with PBS three times. After that, the cells were blocked with 0.4% FBS in PBST for 5 min and then washed with PBS. The cells were incubated with primary antibody at 4 C overnight. The antibodies used are as follows: mouse monoclonal antibodies against FLAG (Sigma), HA (Santa Cruz Biotechnology), a-tubulin (Proteintech) and c-tubulin (Sigma). After the primary antibodies were removed and washed, the secondary antibody Alexa Fluor 594-conjugated AffiniPure donkey anti-mouse IgG (Invitrogen) was added and incubated at room temperature for 2 h. Finally, the cells were incubated with 4 0 6-diamidino-2-phenylindole (DAPI, Sigma) (blue) for 1 min to stain the nuclei. The cells were observed using an inverted fluorescence microscope (Olympus IX71) or a confocal microscope (Zeiss LSM 710).
Immunoprecipitation
HEK 293 cells were collected 48 h after transfection and were sonicated in lysis buffer. The cellular debris was removed by centrifugation at 12 000 rpm for 30 min at 4 C. The supernatants were incubated with polyclonal anti-GFP antibodies overnight at 4 C. 
RNA interference
Double-stranded oligonucleotides (siRNA) synthesized by Shanghai GenePharma (Shanghai, China) were designed against the human Hrd1 cDNA. The sequences for the siRNA against Hrd1 are: sense 5 0 -AAGGUGAUGGGCAAGGUGUUCTT-3 and anti-sense 5 0 -GAACACCUUGCCCAUCACCUUTT-3. Meanwhile, an irrelevant oligonucleotide served as a negative control.
Supplementary Material
Supplementary Material is available at HMG online.
